Genomma Lab Internacional Announces Long-Term Debt Refinancing Transaction

Barchart · 3d ago

MEXICO CITY, July 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international reach, today announced it has entered into a long-term credit facility to refinance its existing financial liabilities.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.